The influence of EDTMP-concentration on the biodistribution of radio-lanthanides and 225-Ac in tumor-bearing mice

被引:41
作者
Beyer, GJ
Offord, R
Kunzi, G
Aleksandrova, Y
Ravn, U
Jahn, S
Barker, J
Tengblad, O
Lindroos, M
机构
[1] UNIV GENEVA, HOP CANTONAL, DIV NUCL MED, CH-1211 GENEVA 23, SWITZERLAND
[2] UNIV GENEVA, DEPT BIOCHEM MED, CH-1211 GENEVA 23, SWITZERLAND
[3] CERN, DIV PPE, CH-1211 GENEVA 23, SWITZERLAND
关键词
radio-lanthanides; actinium; radionuclide therapy; EDTMP; biokinetic;
D O I
10.1016/S0969-8051(97)00011-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
High resolution gamma spectroscopy was applied to measure simultaneously the biodistribution of carrier-free radionuclides of several lanthanides (Ce-141, Sm-145, Gd-149, Tm-167) and Ac-229 in tumor-bearing nude mice. Mixtures of the radiotracers were injected in solutions containing different concentrations of EDTMP (ethylenediaminetetramethylenephosphonic acid). The strong dependence of liver uptake on the ionic radius of the radio-lanthanides was confirmed for all tracers used. The ratios of radioactivity concentrated in tumor to that concentrated in liver are strongly influenced by the EDTMP concentration, reaching values close to 10 for Tm, 3 for Sm, and 1 for Ac. The optimal EDTMP concentrations, giving highest tumor-to-liver ratios of enrichment, were between 1 and 10 mM for 100 mu L injected volume for the animal model used in this experiment. In radionuclide therapy using EDTMP as ligands, close control of ligand concentration will be necessary. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:367 / 372
页数:6
相关论文
共 20 条
  • [1] Alpha- and beta-emitting radiolanthanides in targeted cancer therapy: The potential role of terbium-149
    Allen, BJ
    Blagojevic, N
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 1996, 17 (01) : 40 - 47
  • [2] ANDO A, 1983, EUR J NUCL MED, V8, P440
  • [3] MECHANISM OF TUMOR AND LIVER CONCENTRATION OF IN-111 AND YB-169 - IN-111 AND YB-169 BINDING SUBSTANCES IN TUMOR-TISSUES AND LIVER
    ANDO, A
    ANDO, I
    HIRAKI, T
    TAKESHITA, M
    HISADA, K
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1982, 7 (07): : 298 - 303
  • [4] BEYER GJ, 1992, NUCL MED BIOL, V19, P201
  • [5] COMPARISON OF THE BIODISTRIBUTION OF AC-225 AND RADIOLANTHANIDES AS CITRATE COMPLEXES
    BEYER, GJ
    BERGMANN, R
    SCHOMACKER, K
    ROSCH, F
    SCHAFER, G
    KULIKOV, EV
    NOVGORODOV, AF
    [J]. ISOTOPENPRAXIS, 1990, 26 (03): : 111 - 114
  • [6] COMPARATIVE KINETIC STUDIES OF SIMULTANEOUSLY INJECTED CITRATE-TM-167 AND CITRATE-GA-67 IN NORMAL AND TUMOR BEARING MICE
    BEYER, GJ
    FRANKE, WG
    HENNIG, K
    JOHANNSEN, BA
    KHALKIN, VA
    KRETZSCHMAR, M
    LEBEDEV, NA
    MUNZE, R
    NOVGORODOV, AF
    THIEME, K
    [J]. INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES, 1978, 29 (11): : 673 - 681
  • [7] BEYER GJ, 1995, EUROPEAN J NUCL MED, V22, P914
  • [8] BEYER GJ, 1981, RADIONUCLIDE IMAGING, V1, P587
  • [9] BEYER GJ, 1989, ZFK669, P98
  • [10] Garlich J.R., 1990, US Patent, Patent No. [4937333, A, 4937333, US4937333]